017IC - Emerging Concepts in Interstitial Cystitis/ Bladder Pain Syndrome

Friday, April 28, 2023

1:30 PM – 3:30 PM CST

Location: S105A

Instructional Course Director(s)

JC

J. Quentin Clemens, MD

Edward J. McGuire Professor of Urology
University of Michigan Medical Center

Instructional Course Faculty(s)

LA

Lenore Ackerman, MD, PhD (she/her/hers)

Assistant Professor of Urology
University of California, Los Angeles
Henry Lai, MD

Professor of Urology and Anesthesiology
Washington University School of Medicine

Course Description: This course on interstitial cystitis/bladder pain syndrome is designed for the urologist, gynecologist and advanced practice provider who see these patients and are responsible for their medical care. It is designed to focus on what we know, what we have learned from recent research efforts, how we can best use our knowledge in the care of these patients, and what may be coming in the future. We will discuss definition, nomenclature, epidemiology and possible etiology, and review the recently updated American Urological Association Guideline which provides a working framework from which to practice. We will discuss emerging data about the diagnosis and management of patients with Hunner lesion disease. We will review the major findings of the National Institute of Diabetes and Digestive and Kidney Diseases Multidisciplinary Approach to the study of Chronic Pelvic Pain Research Network, which is completing over a decade of intensive research on this syndrome. How might this research inform and translate into the clinical arena and help our patients now and in the future? The session will conclude with questions and comments from the attendees.

Learning Objectives:

Review the recent updates to the AUA Guidelines and how these changes impact patient management.
Describe the major findings for the National Institute of Diabetes and Digestive and Kidney Diseases Multidisciplinary Approach to the study of Chronic Pelvic Pain research effort and its current and potential future impact on patient care.
Outline the importance of identifying patients with Hunner lesions and how the treatment approach differs for these patients.
Discuss important patient subtypes in patients without Hunner lesions and how these specific patient characteristics can guide patient care.
Summarize the ocular complications that have been associated with pentosan polysulfate sodium and the U.S. Food and Drug Administration recommendations for this issue.